Clinical Trials

Today's treatments are tomorrow's cures. The Cancer Institute of New Jersey's physician-scientists work together to bring the most innovative clinical trials to our patients. As an NCI-designated Comprehensive Cancer Center, patients have access to treatment options that may not be available elsewhere. 

Clinical Trials at Rutgers Cancer Institute of New Jersey

Clinical Trials Overview


Clinical trials are research studies in which patients may volunteer to take part. Rutgers Cancer Institute of New Jersey uses clinical trials to find better ways to prevent, diagnose and treat cancer. As one of the National Cancer Institute’s designated cancer centers, Rutgers Cancer Institute of New Jersey is able to provide access to clinical trials not available at other hospitals, clinics or doctor’s offices, as well as access to some of the most advanced, targeted treatments and medicines available. Rutgers Cancer Institute of New Jersey is committed to providing the latest and best treatment options for cancer patients through clinical trials - outsmarting cancer with science.

All of today’s successful treatments for cancer are based on results of past clinical trials. Because of progress made through clinical trials, people treated for cancer are living longer today. Rutgers Cancer Institute currently enrolls approximately 17 percent of all its new adult cancer patients and approximately 70 percent of all pediatric cancer patients on clinical trials. Enrollment in clinical trials nationwide is fewer than five percent of all adult cancer patients.

For more information about our clinical trials call 732-235-8675 or search for a clinical trial.

Understanding Cancer Clinical Trials

Why are cancer clinical trials important?

In this video, Rutgers Cancer Institute's Dr. Janice Mehnert, Director, Regional Phase I Clinical Program, and Dr. Ann Silk, Medical Oncologist, discuss why it's important to consider cancer clinical trials as part of a patient's treatment plan.

Why participate in a clinical trial?

For many cancers, standard therapy may not be sufficient to have great success. To find the most effective treatments, researchers are constantly looking for the next generation of therapies, and the only way to make those discoveries is clinical trials.

In this video, Steven Libutti, MD, Senior Vice President of Oncology Services, RWJBarnabas Health and Director, Rutgers Cancer Institute of New Jersey, explains why cancer care and cancer research are two sides of the same coin. For more information about cancer services at RWJBarnabas Health, please visit 




precision medicine at Rutgers Cancer Institute







Donate Now








Proud member of
Big Ten Cancer Research Consortium



Rutgers Health